Lenalidomide results in a durable complete remission in acute myeloid leukemia accompanied by persistence of somatic mutations and a T-cell infiltrate in the bone marrow

Dhruv Bansal, Washington University School of Medicine in St. Louis
Kiran Vij, Washington University School of Medicine in St. Louis
Gue Su Chang, Washington University School of Medicine in St. Louis
Christopher A. Miller, Washington University School of Medicine in St. Louis
John F. DiPersio, Washington University School of Medicine in St. Louis
Ravi Vig, Washington University School of Medicine in St. Louis
Sharon E. Heath, Washington University School of Medicine in St. Louis
Peter Westervelt, Washington University School of Medicine in St. Louis
John S. Welch, Washington University School of Medicine in St. Louis
Todd A. Fehniger, Washington University School of Medicine in St. Louis

Abstract